Select Page

Indian startup PredOmix develops an AI-powered blood test that can identify approximately 32 types of cancer in men and women with about 98 per cent accuracy. Based on OncoVeryx-F, a patented technology developed by the company, employs a combination of metabolomics (the study of small molecules) and artificial intelligence to detect metabolite signatures of various types of cancer in a single test.

Read the original article here: